Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment

To assess whether age, at the beginning of biologic treatment, is associated with the time a first adverse event (AE) appears in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), or psoriatic arthritis (PsA). All patients in the BIOBADASER registry diagnosed with RA, AS, and PsA,...

Descripción completa

Detalles Bibliográficos
Autores: Vela, Paloma|||0000-0001-8566-5172, Sanchez-Piedra, Carlos, Pérez-García, Carolina|||0000-0002-6695-6406, Castro-Villegas, Ma Carmen, Freire, Mercedes, Mateo, Lourdes|||0000-0002-6394-2949, Diaz-Torne, Cesar|||0000-0001-6275-7699, Bohórquez, Cristina, Blanco-Madrigal, Juan M., Ros-Vilamajo, Inmaculada, Gómez, Silvia, Caño, Rocio, Sánchez-Alonso, Fernando, Díaz-González, Federico|||0000-0002-4139-9295, Gómez-Reino, Juan J.
Tipo de recurso: artículo
Fecha de publicación:2020
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:284609
Acceso en línea:https://ddd.uab.cat/record/284609
https://dx.doi.org/urn:doi:10.1186/s13075-020-02231-x
Access Level:acceso abierto
Palabra clave:Ankylosing spondylitis
Biologics
Elderly-onset rheumatoid arthritis
Psoriatic arthritis
Rheumatoid arthritis
id ES_e438059cd0df0e6e6931775766aa6f64
oai_identifier_str oai:ddd.uab.cat:284609
network_acronym_str ES
network_name_str España
repository_id_str
spelling Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatmentData from the BIOBADASER III registerVela, Paloma|||0000-0001-8566-5172Sanchez-Piedra, CarlosPérez-García, Carolina|||0000-0002-6695-6406Castro-Villegas, Ma CarmenFreire, MercedesMateo, Lourdes|||0000-0002-6394-2949Diaz-Torne, Cesar|||0000-0001-6275-7699Bohórquez, CristinaBlanco-Madrigal, Juan M.Ros-Vilamajo, InmaculadaGómez, SilviaCaño, RocioSánchez-Alonso, FernandoDíaz-González, Federico|||0000-0002-4139-9295Gómez-Reino, Juan J.Ankylosing spondylitisBiologicsElderly-onset rheumatoid arthritisPsoriatic arthritisRheumatoid arthritisTo assess whether age, at the beginning of biologic treatment, is associated with the time a first adverse event (AE) appears in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), or psoriatic arthritis (PsA). All patients in the BIOBADASER registry diagnosed with RA, AS, and PsA, and classified as young (< 25 years old), adult (25-64 years old), elderly (65-75 years old) or very elderly (.Universitat Autònoma de Barcelona 22020-01-0120202020-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/284609https://dx.doi.org/urn:doi:10.1186/s13075-020-02231-xreponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2846092026-06-06T12:50:31Z
dc.title.none.fl_str_mv Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment
Data from the BIOBADASER III register
title Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment
spellingShingle Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment
Vela, Paloma|||0000-0001-8566-5172
Ankylosing spondylitis
Biologics
Elderly-onset rheumatoid arthritis
Psoriatic arthritis
Rheumatoid arthritis
title_short Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment
title_full Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment
title_fullStr Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment
title_full_unstemmed Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment
title_sort Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment
dc.creator.none.fl_str_mv Vela, Paloma|||0000-0001-8566-5172
Sanchez-Piedra, Carlos
Pérez-García, Carolina|||0000-0002-6695-6406
Castro-Villegas, Ma Carmen
Freire, Mercedes
Mateo, Lourdes|||0000-0002-6394-2949
Diaz-Torne, Cesar|||0000-0001-6275-7699
Bohórquez, Cristina
Blanco-Madrigal, Juan M.
Ros-Vilamajo, Inmaculada
Gómez, Silvia
Caño, Rocio
Sánchez-Alonso, Fernando
Díaz-González, Federico|||0000-0002-4139-9295
Gómez-Reino, Juan J.
author Vela, Paloma|||0000-0001-8566-5172
author_facet Vela, Paloma|||0000-0001-8566-5172
Sanchez-Piedra, Carlos
Pérez-García, Carolina|||0000-0002-6695-6406
Castro-Villegas, Ma Carmen
Freire, Mercedes
Mateo, Lourdes|||0000-0002-6394-2949
Diaz-Torne, Cesar|||0000-0001-6275-7699
Bohórquez, Cristina
Blanco-Madrigal, Juan M.
Ros-Vilamajo, Inmaculada
Gómez, Silvia
Caño, Rocio
Sánchez-Alonso, Fernando
Díaz-González, Federico|||0000-0002-4139-9295
Gómez-Reino, Juan J.
author_role author
author2 Sanchez-Piedra, Carlos
Pérez-García, Carolina|||0000-0002-6695-6406
Castro-Villegas, Ma Carmen
Freire, Mercedes
Mateo, Lourdes|||0000-0002-6394-2949
Diaz-Torne, Cesar|||0000-0001-6275-7699
Bohórquez, Cristina
Blanco-Madrigal, Juan M.
Ros-Vilamajo, Inmaculada
Gómez, Silvia
Caño, Rocio
Sánchez-Alonso, Fernando
Díaz-González, Federico|||0000-0002-4139-9295
Gómez-Reino, Juan J.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universitat Autònoma de Barcelona
dc.subject.none.fl_str_mv Ankylosing spondylitis
Biologics
Elderly-onset rheumatoid arthritis
Psoriatic arthritis
Rheumatoid arthritis
topic Ankylosing spondylitis
Biologics
Elderly-onset rheumatoid arthritis
Psoriatic arthritis
Rheumatoid arthritis
description To assess whether age, at the beginning of biologic treatment, is associated with the time a first adverse event (AE) appears in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), or psoriatic arthritis (PsA). All patients in the BIOBADASER registry diagnosed with RA, AS, and PsA, and classified as young (< 25 years old), adult (25-64 years old), elderly (65-75 years old) or very elderly (.
publishDate 2020
dc.date.none.fl_str_mv 2
2020-01-01
2020
2020-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/284609
https://dx.doi.org/urn:doi:10.1186/s13075-020-02231-x
url https://ddd.uab.cat/record/284609
https://dx.doi.org/urn:doi:10.1186/s13075-020-02231-x
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869422571704811520
score 15,300724

Similares en LA Referencia